{"pmid":32294453,"title":"Current Resources for Evidence-Based Practice, May 2020.","text":["Current Resources for Evidence-Based Practice, May 2020.","An extensive review of new resources to support the provision of evidence-based care for women and infants. The current column includes a discussion of a new National Academy of Medicine report on planned place of birth and implications during the SARS-CoV-2 pandemic and commentaries on reviews focused on anorectal sexually transmitted infections and feeding methods following cleft lip repair in infants.","J Obstet Gynecol Neonatal Nurs","Bovbjerg, Marit L","32294453"],"abstract":["An extensive review of new resources to support the provision of evidence-based care for women and infants. The current column includes a discussion of a new National Academy of Medicine report on planned place of birth and implications during the SARS-CoV-2 pandemic and commentaries on reviews focused on anorectal sexually transmitted infections and feeding methods following cleft lip repair in infants."],"journal":"J Obstet Gynecol Neonatal Nurs","authors":["Bovbjerg, Marit L"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294453","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jogn.2020.04.001","source":"PubMed","weight":0,"_version_":1664266295863934976,"score":8.233237,"similar":[{"pmid":32266184,"pmcid":"PMC7098456","title":"Infants Born to Mothers With a New Coronavirus (COVID-19).","text":["Infants Born to Mothers With a New Coronavirus (COVID-19).","A novel viral respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for an epidemic of the coronavirus disease 2019 (COVID-19) in cases in China and worldwide. Four full-term, singleton infants were born to pregnant women who tested positive for COVID-19 in the city of Wuhan, the capital of Hubei province, China, where the disease was first identified. Of the three infants, for who consent to be diagnostically tested was provided, none tested positive for the virus. None of the infants developed serious clinical symptoms such as fever, cough, diarrhea, or abnormal radiologic or hematologic evidence, and all four infants were alive at the time of hospital discharge. Two infants had rashes of unknown etiology at birth, and one had facial ulcerations. One infant had tachypnea and was supported by non-invasive mechanical ventilation for 3 days. One had rashes at birth but was discharged without parental consent for a diagnostic test. This case report describes the clinical course of four live born infants, born to pregnant women with the COVID-19 infection.","Front Pediatr","Chen, Yan","Peng, Hua","Wang, Lin","Zhao, Yin","Zeng, Lingkong","Gao, Hui","Liu, Yalan","32266184"],"abstract":["A novel viral respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for an epidemic of the coronavirus disease 2019 (COVID-19) in cases in China and worldwide. Four full-term, singleton infants were born to pregnant women who tested positive for COVID-19 in the city of Wuhan, the capital of Hubei province, China, where the disease was first identified. Of the three infants, for who consent to be diagnostically tested was provided, none tested positive for the virus. None of the infants developed serious clinical symptoms such as fever, cough, diarrhea, or abnormal radiologic or hematologic evidence, and all four infants were alive at the time of hospital discharge. Two infants had rashes of unknown etiology at birth, and one had facial ulcerations. One infant had tachypnea and was supported by non-invasive mechanical ventilation for 3 days. One had rashes at birth but was discharged without parental consent for a diagnostic test. This case report describes the clinical course of four live born infants, born to pregnant women with the COVID-19 infection."],"journal":"Front Pediatr","authors":["Chen, Yan","Peng, Hua","Wang, Lin","Zhao, Yin","Zeng, Lingkong","Gao, Hui","Liu, Yalan"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266184","week":"202015|Apr 06 - Apr 12","doi":"10.3389/fped.2020.00104","keywords":["COVID-19 infected mothers","China","clinical course","newborns","vertical transmission"],"source":"PubMed","locations":["Hubei","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663609715726221312,"score":77.82171},{"pmid":32294229,"title":"COVID-19 vaginal delivery - a case report.","text":["COVID-19 vaginal delivery - a case report.","The novel coronavirus termed SARS-CoV-2 is a major public health challenge. Many maternity units around the country are currently considering management protocols for these patients. We report a case from a tertiary Australian hospital describing an uncomplicated vaginal birth in a SARS-CoV-2 positive mother. To our knowledge this is also the first case described of a mother with COVID-19 not separated from her infant. Management provided supports the current Royal College of Obstetricians and Gynaecologists and World Health Organization guidelines suggesting that it is possible to consider rooming in post delivery for COVID-19 positive parents. Encouragement of breast feeding appears possible and safe when viral precautions are observed.","Aust N Z J Obstet Gynaecol","Lowe, Belinda","Bopp, Benjamin","32294229"],"abstract":["The novel coronavirus termed SARS-CoV-2 is a major public health challenge. Many maternity units around the country are currently considering management protocols for these patients. We report a case from a tertiary Australian hospital describing an uncomplicated vaginal birth in a SARS-CoV-2 positive mother. To our knowledge this is also the first case described of a mother with COVID-19 not separated from her infant. Management provided supports the current Royal College of Obstetricians and Gynaecologists and World Health Organization guidelines suggesting that it is possible to consider rooming in post delivery for COVID-19 positive parents. Encouragement of breast feeding appears possible and safe when viral precautions are observed."],"journal":"Aust N Z J Obstet Gynaecol","authors":["Lowe, Belinda","Bopp, Benjamin"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32294229","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajo.13173","keywords":["Breastfeeding","COVID-19","Coronavirus","Neonatal","Vaginal delivery"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["Australian"],"countries":["Australia"],"countries_codes":["AUS|Australia"],"_version_":1664266295603888128,"score":76.57025},{"pmid":32289472,"title":"Evidence Based Management Guideline for the COVID-19 Pandemic - Review article.","text":["Evidence Based Management Guideline for the COVID-19 Pandemic - Review article.","COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 944,181 people worldwide, resulting in over 47,312 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have been employed to mitigate the spread of disease including careful infection control, the isolation of patients, and social distancing. Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention. Medical therapy involving corticosteroids and antivirals have also been encouraged as part of critical management schemes. However, there is at present no specific antiviral recommended for the treatment of COVID-19, and no vaccine is currently available. Despite the strategic implementation of these measures, the number of new reported cases continues to rise at a profoundly alarming rate. As new findings emerge, there is an urgent need for up-to-date management guidelines. In response to this call, we review what is currently known regarding the management of COVID-19, and offer an evidence-based review of current practice.","Int J Surg","Nicola, Maria","O'Neill, Niamh","Sohrabi, Catrin","Khan, Mehdi","Agha, Maliha","Agha, Riaz","32289472"],"abstract":["COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 944,181 people worldwide, resulting in over 47,312 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have been employed to mitigate the spread of disease including careful infection control, the isolation of patients, and social distancing. Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention. Medical therapy involving corticosteroids and antivirals have also been encouraged as part of critical management schemes. However, there is at present no specific antiviral recommended for the treatment of COVID-19, and no vaccine is currently available. Despite the strategic implementation of these measures, the number of new reported cases continues to rise at a profoundly alarming rate. As new findings emerge, there is an urgent need for up-to-date management guidelines. In response to this call, we review what is currently known regarding the management of COVID-19, and offer an evidence-based review of current practice."],"journal":"Int J Surg","authors":["Nicola, Maria","O'Neill, Niamh","Sohrabi, Catrin","Khan, Mehdi","Agha, Maliha","Agha, Riaz"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32289472","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ijsu.2020.04.001","keywords":["COVID-19","SARS-CoV-2","management guidelines","pandemic"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664071627198955521,"score":73.88094},{"pmid":32238177,"pmcid":"PMC7112750","title":"Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","text":["Emerging infectious diseases and outbreaks: implications for women's reproductive health and rights in resource-poor settings.","This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings.","Reprod Health","Chattu, Vijay Kumar","Yaya, Sanni","32238177"],"abstract":["This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings."],"journal":"Reprod Health","authors":["Chattu, Vijay Kumar","Yaya, Sanni"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238177","week":"202014|Mar 30 - Apr 05","doi":"10.1186/s12978-020-0899-y","keywords":["Covid-19","Ebola","Emerging and re-emerging infectious diseases (EIDs)","Gender","Low- and middle-income countries (LMICs)","SARS","Sexual and reproductive health and rights (SRHRs)","Sustainable developmental goals (SDGs)","Women","Zika"],"source":"PubMed","locations":["Ebolavirus"],"weight":0,"_version_":1663352135693107200,"score":72.25291},{"pmid":32238615,"title":"Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP).","text":["Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP).","JUSTIFICATION: During the current rapidly evolving pandemic of COVID-19 infection, pregnant women with suspected or confirmed COVID-19 and their newborn infants form a special vulnerable group that needs immediate attention. Unlike other elective medical and surgical problems for which care can be deferred during the pandemic, pregnancies and childbirths will continue. Perinatal period poses unique challenges and care of the mother-baby dyads requires special resources for prevention of transmission, diagnosis of infection and providing clinical care during labor, resuscitation and postnatal period. PROCESS: The GRADE approach recommended by the World Health Organization was used to develop the guideline. A Guideline Development Group (GDG) comprising of obstetricians, neonatologists and pediatricians was constituted. The GDG drafted a list of questions which are likely to be faced by clinicians involved in obstetric and neonatal care. An e-survey was carried out amongst a wider group of clinicians to invite more questions and prioritize. Literature search was carried out in PubMed and websites of relevant international and national professional organizations. Existing guidelines, systematic reviews, clinical trials, narrative reviews and other descriptive reports were reviewed. For the practice questions, the evidence was extracted into evidence profiles. The context, resources required, values and preferences were considered for developing the recommendations. OBJECTIVES: To provide recommendations for prevention of transmission, diagnosis of infection and providing clinical care during labor, resuscitation and postnatal period. RECOMMENDATIONS: A set of twenty recommendations are provided under the following broad headings: 1) pregnant women with travel history, clinical suspicion or confirmed COVID-19 infection; 2) neonatal care; 3) prevention and infection control; 4) diagnosis; 5) general questions.","Indian Pediatr","Chawla, Deepak","Chirla, Dinesh","Dalwai, Samir","Deorari, Ashok K","Ganatra, Atul","Gandhi, Alpesh","Kabra, Nandkishor S","Kumar, Praveen","Mittal, Pratima","Parekh, Bakul Jayant","Sankar, M Jeeva","Singhal, Tanu","Sivanandan, Sindhu","Tank, Parikshit","32238615"],"abstract":["JUSTIFICATION: During the current rapidly evolving pandemic of COVID-19 infection, pregnant women with suspected or confirmed COVID-19 and their newborn infants form a special vulnerable group that needs immediate attention. Unlike other elective medical and surgical problems for which care can be deferred during the pandemic, pregnancies and childbirths will continue. Perinatal period poses unique challenges and care of the mother-baby dyads requires special resources for prevention of transmission, diagnosis of infection and providing clinical care during labor, resuscitation and postnatal period. PROCESS: The GRADE approach recommended by the World Health Organization was used to develop the guideline. A Guideline Development Group (GDG) comprising of obstetricians, neonatologists and pediatricians was constituted. The GDG drafted a list of questions which are likely to be faced by clinicians involved in obstetric and neonatal care. An e-survey was carried out amongst a wider group of clinicians to invite more questions and prioritize. Literature search was carried out in PubMed and websites of relevant international and national professional organizations. Existing guidelines, systematic reviews, clinical trials, narrative reviews and other descriptive reports were reviewed. For the practice questions, the evidence was extracted into evidence profiles. The context, resources required, values and preferences were considered for developing the recommendations. OBJECTIVES: To provide recommendations for prevention of transmission, diagnosis of infection and providing clinical care during labor, resuscitation and postnatal period. RECOMMENDATIONS: A set of twenty recommendations are provided under the following broad headings: 1) pregnant women with travel history, clinical suspicion or confirmed COVID-19 infection; 2) neonatal care; 3) prevention and infection control; 4) diagnosis; 5) general questions."],"journal":"Indian Pediatr","authors":["Chawla, Deepak","Chirla, Dinesh","Dalwai, Samir","Deorari, Ashok K","Ganatra, Atul","Gandhi, Alpesh","Kabra, Nandkishor S","Kumar, Praveen","Mittal, Pratima","Parekh, Bakul Jayant","Sankar, M Jeeva","Singhal, Tanu","Sivanandan, Sindhu","Tank, Parikshit"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238615","week":"202014|Mar 30 - Apr 05","source":"PubMed","topics":["Prevention","Diagnosis"],"weight":1,"_version_":1663352135676329984,"score":70.12876}]}